Cadila Healthcare informs about press release

16 Mar 2019 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated March 16, 2019 titled ‘Zydus receives final approval from the USFDA for Valsartan and Hydrochlorothiazide Tablets’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1013.75 14.15 (1.42%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.